david charles Archives
Jun. 30, 2020—A pair of ultra-thin electrodes surgically implanted deep into the brain might slow the progression of Parkinson’s disease, according to five-year outcomes from a 30-patient randomized clinical trial conducted by investigators at Vanderbilt University Medical Center.
Aug. 30, 2018—A decade after taking part in the first clinical trial of deep brain stimulation (DBS) administered during very early-stage Parkinson’s disease, participants will return to Vanderbilt University Medical Center this year to be re-evaluated.
Jul. 26, 2018—The National Institutes of Health (NIH) has renewed Vanderbilt University Medical Center’s membership in NeuroNEXT, a research network that helps streamline Phase 2 clinical trials for brain disorders.
Jun. 29, 2018—June 29, 2018 - Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may possibly delay the progression of one of the cardinal features of Parkinson’s disease.
Sep. 1, 2016—A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients.
Aug. 18, 2016—Vanderbilt Heart and Vascular Institute cardiologist Allen Naftilan, M.D., Ph.D., puts a stethoscope to his ears and listens to the heartbeats of patients more than 90 miles away.
Apr. 5, 2016—Last week, David Charles, M.D., chief medical officer of the Vanderbilt Neuroscience Institute, vice-chair of the Department of Neurology and medical director of Telemedicine, represented Vanderbilt University Medical Center at a White House Convening on Rural Telehealth.
Aug. 27, 2015—For patients suffering from a stroke, the key to a positive outcome often hinges on how quickly they can receive a brain-saving medical intervention.
Sep. 4, 2014—In the same way scientists from the Vanderbilt Clinical Neuroscience Scholars (CNS) Program have benefited from their experiences in the clinical setting, an initiative is underway for Psychiatry, Neurology and Neurosurgery residents to have an opportunity to do bench work in the basic science labs.
May. 1, 2014—After eight Department of Anesthesiology faculty members recently passed neurocritical care board exams offered by the United Council for Neurologic Subspecialties, Vanderbilt University Medical Center (VUMC) now boasts one of the largest contingents of practicing neurointensivists in the United States. A neurointensivist is a physician who cares for patients in the Neurological ICU. The neurointensivist...